D. Raben

发表

HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)’s 2010 HIV testing guidance

J. Lundgren, A. Amato-Gauci, A. Sullivan, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Late presentation of HIV infection: a consensus definition

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2011, HIV medicine.

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

D. Raben, F. Tanser, C. Chimbetete, 2016, International journal of epidemiology.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

HIV post-test practices: an online survey examining perceived delivery of HIV test results, post-test discussion and referral in healthcare settings across the WHO European Region.

D. Raben, J. D. de Wit, N. Tsereteli, 2016, Sexual health.

Lessons learned from the first European project on the integration of infectious diseases in testing services, data collection and country responses

J. Lazarus, A. Sullivan, D. Raben, 2021, BMC Infectious Diseases.

Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

A. Mocroft, O. Kirk, D. Raben, 2021, HIV research & clinical practice.

Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe

A. Mocroft, O. Kirk, C. Sabin, 2017, AIDS.

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain

A. Sullivan, D. Raben, R. Matulionytė, 2021, BMC Infectious Diseases.

Implementation of indicator condition guided HIV testing still lagging behind the evidence

A. Sullivan, D. Raben, 2021, EClinicalMedicine.

A call to action toward integrated testing and earlier care for viral hepatitis, HIV, STIs and TB

B. Gazzard, J. Lazarus, J. Lundgren, 2020 .

Defining linkage to care following human immunodeficiency virus (HIV) diagnosis for public health monitoring in Europe

A. Copas, D. Raben, S. F. Jakobsen, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015

A. Mocroft, O. Kirk, A. Blaxhult, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines

Henrik Nielsen, J. Lundgren, D. Raben, 2022, Frontiers in Medicine.

A call to action to reclaim focus on testing and early treatment for HIV, viral hepatitis, sexually transmitted infections and tuberculosis

J. Lazarus, D. Raben, J. Rockstroh, 2022, International journal of STD & AIDS.

Late diagnosis of HIV: An updated consensus definition

O. Kirk, J. Lazarus, A. Pharris, 2022, HIV medicine.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Hansjakob Furrer, Manuel Battegay, Pietro Vernazza, 2019, The Lancet.

Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

J. Sterne, A. Mocroft, A. d’Arminio Monforte, 2016, International journal of epidemiology.

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis

A. d’Arminio Monforte, D. Raben, F. Dabis, 2019, Journal of viral hepatitis.

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Richard D Moore, K. Anastos, O. Kirk, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord

D. Raben, J. Rockstroh, F. Dabis, 2015, BMC Infectious Diseases.

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020

D. Raben, A. Stengaard, D. Simões, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Late presentation of chronic viral hepatitis for medical care: a consensus definition

M. Buti, J. Lazarus, J. Gatell, 2017, BMC Medicine.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

The EuroSIDA study: 25 years of scientific achievements

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, HIV medicine.

P. Vanhems, O. Kirk, R. Paredes, 2014 .

Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)

Stefan Esser, Josip Begovac, Jens D. Lundgren, 2013, PloS one.

HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.

J. Lazarus, A. Pharris, A. Sullivan, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015.

A. Mocroft, M. Battegay, D. Raben, 2021, AIDS.

A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations

C. Morrison, P. Vanhems, A. Kamali, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance

A. Sullivan, D. Raben, S. F. Jakobsen, 2019, HIV medicine.

The case for indicator condition‐guided HIV screening

J. Lundgren, J. Lazarus, J. Lundgren, 2013, HIV medicine.

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.

Anne M Johnson, A. Mocroft, O. Kirk, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study

A. Grzeszczuk, M. L. Jakobsen, J. Minton, 2015, PloS one.

Increasing integrated testing in community settings through interventions for change, including the Spring European Testing Week

M. Rosińska, D. Raben, Piotr Wysocki, 2021, BMC Infectious Diseases.

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

A. Amato-Gauci, A. Sullivan, D. Raben, 2019, HIV medicine.

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study

Henrik Nielsen, J. Lundgren, D. Raben, 2022, Clinical Microbiology and Infection.

Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions

J. Lundgren, I. Sperle, D. Raben, 2016, HIV medicine.

HIV pre-test information, discussion or counselling? A review of guidance relevant to the WHO European Region

D. Raben, J. D. de Wit, N. Tsereteli, 2016, International journal of STD & AIDS.